JP Stock MarketDetailed Quotes

Kubota Pharmaceutical Holdings (4596)

Watchlist
  • 77
  • -3-3.75%
20min DelayTrading May 14 14:29 JST
10.80BMarket Cap-7.27P/E (Static)

Kubota Pharmaceutical Holdings (4596) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
-21.53%21.34M
43.86%7.25M
-31.83%27.19M
-60.60%4.75M
-2.76%5.04M
383.24%39.89M
73.07%9.32M
364.80%13.34M
12.05M
5.18M
Cost of revenue
406.77%26.13M
-21.86%815K
-56.20%5.16M
-74.22%1.06M
-48.80%1.04M
102.25%11.77M
-30.98%2.2M
30.36%3.43M
4.1M
2.04M
Gross profit
-121.78%-4.8M
61.03%6.43M
-21.63%22.03M
-53.57%3.69M
27.08%3.99M
1,055.53%28.11M
224.18%7.12M
4,078.90%9.9M
7.95M
3.14M
Operating expense
-34.91%890.06M
-22.25%265.46M
-10.74%1.37B
10.20%341.47M
-23.88%341.41M
-24.91%1.53B
24.19%480.59M
-39.08%293.16M
-41.29%309.87M
-30.41%448.5M
Selling and administrative expenses
-23.58%542.99M
-5.06%167.8M
12.27%710.52M
35.01%201.08M
2.88%176.74M
5.25%632.84M
-8.31%164.96M
-0.33%147.16M
16.42%148.94M
17.81%171.78M
-General and administrative expense
-23.58%542.99M
-5.06%167.8M
12.27%710.52M
35.01%201.08M
2.88%176.74M
5.25%632.84M
-8.31%164.96M
-0.33%147.16M
16.42%148.94M
17.81%171.78M
Research and development costs
-42.90%310.55M
-56.85%71.06M
-31.05%543.84M
-12.76%140.39M
-40.49%164.67M
-47.86%788.79M
-0.93%205.13M
-64.15%146M
-59.75%160.94M
-44.51%276.72M
Other operating expenses
-67.73%36.52M
--26.6M
2.42%113.17M
----
----
--110.5M
----
----
----
----
Total other operating income
----
----
----
----
----
----
----
--0
----
----
Operating profit
33.49%-894.86M
23.23%-259.03M
10.54%-1.35B
-11.88%-337.78M
24.24%-337.41M
26.20%-1.5B
-23.05%-473.47M
41.11%-283.25M
42.80%-301.93M
30.90%-445.36M
Net non-operating interest income (expenses)
158.45%979K
62.78%516K
-136.95%-1.68M
-101.55%-7K
-81.95%317K
-34.30%4.53M
-73.28%1.43M
-78.10%893K
216.84%451K
181.37%1.76M
Non-operating interest income
-67.68%1.85M
-64.43%853K
-58.82%5.73M
-30.79%1.99M
-41.88%2.4M
-24.68%13.91M
-54.40%3.61M
-52.14%3.29M
8.11%2.88M
310.96%4.13M
Non-operating interest expense
-88.22%872K
-83.81%337K
-21.04%7.4M
-17.65%2M
-12.19%2.08M
-18.93%9.37M
-14.73%2.18M
-14.30%2.4M
-20.35%2.43M
-25.05%2.37M
Net investment income
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
Income from associates and other participating interests
Special income (charges)
Other non-operating income (expenses)
1,420.35%217.62M
98.90%-62K
45.01%14.31M
937.12%11.6M
-673.56%-5.65M
-35.12%9.87M
-78.54%9.52M
99.48%-37K
108.52%1.12M
91.78%-730K
Income before tax
49.26%-676.25M
24.56%-258.58M
10.52%-1.33B
-8.60%-326.19M
22.86%-342.74M
26.11%-1.49B
-38.05%-462.52M
41.66%-282.4M
44.51%-300.36M
32.22%-444.33M
Income tax
Net income
49.26%-676.25M
24.56%-258.58M
10.52%-1.33B
-8.60%-326.19M
22.86%-342.74M
26.11%-1.49B
-38.05%-462.52M
41.66%-282.4M
44.51%-300.36M
32.22%-444.33M
Net income continuous operations
49.26%-676.25M
24.56%-258.58M
10.52%-1.33B
-8.60%-326.19M
22.86%-342.74M
26.11%-1.49B
-38.05%-462.52M
41.66%-282.4M
44.51%-300.36M
32.22%-444.33M
Noncontrolling interests
Net income attributable to the company
49.26%-676.25M
24.56%-258.58M
10.52%-1.33B
-8.60%-326.19M
22.86%-342.74M
26.11%-1.49B
-38.05%-462.52M
41.66%-282.4M
44.51%-300.36M
32.22%-444.33M
Preferred stock dividends
Other under preferred stock dividend
0
0
0
0
0
0
0
0
0
0
Net income attributable to common stockholders
49.26%-676.25M
24.56%-258.58M
10.52%-1.33B
-8.60%-326.19M
22.86%-342.74M
26.11%-1.49B
-38.05%-462.52M
41.66%-282.4M
44.51%-300.36M
32.22%-444.33M
Gross dividend payment
Basic earnings per share
55.22%-10.59
26.39%-4.49
11.72%-23.65
-7.02%-5.79
24.60%-6.1
34.53%-26.79
-44.41%-8.26
46.46%-5.06
53.88%-5.41
43.43%-8.09
Diluted earnings per share
55.22%-10.59
26.39%-4.49
11.72%-23.65
-7.02%-5.79
24.60%-6.1
34.53%-26.79
-44.41%-8.26
46.46%-5.06
53.88%-5.41
43.43%-8.09
Dividend per share
Currency Unit
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
Accounting Standards
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
(FY)Dec 31, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue -21.53%21.34M43.86%7.25M-31.83%27.19M-60.60%4.75M-2.76%5.04M383.24%39.89M73.07%9.32M364.80%13.34M12.05M5.18M
Cost of revenue 406.77%26.13M-21.86%815K-56.20%5.16M-74.22%1.06M-48.80%1.04M102.25%11.77M-30.98%2.2M30.36%3.43M4.1M2.04M
Gross profit -121.78%-4.8M61.03%6.43M-21.63%22.03M-53.57%3.69M27.08%3.99M1,055.53%28.11M224.18%7.12M4,078.90%9.9M7.95M3.14M
Operating expense -34.91%890.06M-22.25%265.46M-10.74%1.37B10.20%341.47M-23.88%341.41M-24.91%1.53B24.19%480.59M-39.08%293.16M-41.29%309.87M-30.41%448.5M
Selling and administrative expenses -23.58%542.99M-5.06%167.8M12.27%710.52M35.01%201.08M2.88%176.74M5.25%632.84M-8.31%164.96M-0.33%147.16M16.42%148.94M17.81%171.78M
-General and administrative expense -23.58%542.99M-5.06%167.8M12.27%710.52M35.01%201.08M2.88%176.74M5.25%632.84M-8.31%164.96M-0.33%147.16M16.42%148.94M17.81%171.78M
Research and development costs -42.90%310.55M-56.85%71.06M-31.05%543.84M-12.76%140.39M-40.49%164.67M-47.86%788.79M-0.93%205.13M-64.15%146M-59.75%160.94M-44.51%276.72M
Other operating expenses -67.73%36.52M--26.6M2.42%113.17M----------110.5M----------------
Total other operating income ------------------------------0--------
Operating profit 33.49%-894.86M23.23%-259.03M10.54%-1.35B-11.88%-337.78M24.24%-337.41M26.20%-1.5B-23.05%-473.47M41.11%-283.25M42.80%-301.93M30.90%-445.36M
Net non-operating interest income (expenses) 158.45%979K62.78%516K-136.95%-1.68M-101.55%-7K-81.95%317K-34.30%4.53M-73.28%1.43M-78.10%893K216.84%451K181.37%1.76M
Non-operating interest income -67.68%1.85M-64.43%853K-58.82%5.73M-30.79%1.99M-41.88%2.4M-24.68%13.91M-54.40%3.61M-52.14%3.29M8.11%2.88M310.96%4.13M
Non-operating interest expense -88.22%872K-83.81%337K-21.04%7.4M-17.65%2M-12.19%2.08M-18.93%9.37M-14.73%2.18M-14.30%2.4M-20.35%2.43M-25.05%2.37M
Net investment income
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
Income from associates and other participating interests
Special income (charges)
Other non-operating income (expenses) 1,420.35%217.62M98.90%-62K45.01%14.31M937.12%11.6M-673.56%-5.65M-35.12%9.87M-78.54%9.52M99.48%-37K108.52%1.12M91.78%-730K
Income before tax 49.26%-676.25M24.56%-258.58M10.52%-1.33B-8.60%-326.19M22.86%-342.74M26.11%-1.49B-38.05%-462.52M41.66%-282.4M44.51%-300.36M32.22%-444.33M
Income tax
Net income 49.26%-676.25M24.56%-258.58M10.52%-1.33B-8.60%-326.19M22.86%-342.74M26.11%-1.49B-38.05%-462.52M41.66%-282.4M44.51%-300.36M32.22%-444.33M
Net income continuous operations 49.26%-676.25M24.56%-258.58M10.52%-1.33B-8.60%-326.19M22.86%-342.74M26.11%-1.49B-38.05%-462.52M41.66%-282.4M44.51%-300.36M32.22%-444.33M
Noncontrolling interests
Net income attributable to the company 49.26%-676.25M24.56%-258.58M10.52%-1.33B-8.60%-326.19M22.86%-342.74M26.11%-1.49B-38.05%-462.52M41.66%-282.4M44.51%-300.36M32.22%-444.33M
Preferred stock dividends
Other under preferred stock dividend 0000000000
Net income attributable to common stockholders 49.26%-676.25M24.56%-258.58M10.52%-1.33B-8.60%-326.19M22.86%-342.74M26.11%-1.49B-38.05%-462.52M41.66%-282.4M44.51%-300.36M32.22%-444.33M
Gross dividend payment
Basic earnings per share 55.22%-10.5926.39%-4.4911.72%-23.65-7.02%-5.7924.60%-6.134.53%-26.79-44.41%-8.2646.46%-5.0653.88%-5.4143.43%-8.09
Diluted earnings per share 55.22%-10.5926.39%-4.4911.72%-23.65-7.02%-5.7924.60%-6.134.53%-26.79-44.41%-8.2646.46%-5.0653.88%-5.4143.43%-8.09
Dividend per share
Currency Unit JPYJPYJPYJPYJPYJPYJPYJPYJPYJPY
Accounting Standards NonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAP
Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More